What is empagliflozin/metformin hydrochloride used for?
Empagliflozin and metformin hydrochloride tablets are used to improve blood sugar control in adults with type 2 diabetes. They work by combining:
- Empagliflozin, which helps the kidneys remove glucose from the blood (via the urine)
- Metformin hydrochloride, which reduces glucose production by the liver and improves insulin sensitivity
How do empagliflozin and metformin work together?
The two medicines target different parts of glucose regulation:
- Metformin lowers how much glucose the liver releases and improves how the body responds to insulin.
- Empagliflozin lowers blood glucose by causing excess glucose to be excreted through the kidneys.
Using them together can improve overall glycemic control more than either alone for many patients.
What are the key safety issues people usually ask about?
When these medicines are combined, common concerns include risks associated with each component:
For empagliflozin (SGLT2 inhibitor), patients and clinicians often focus on:
- Genital yeast infections and other urinary/genital infections
- Dehydration or low blood pressure symptoms, especially in people who are older or also take diuretics
- Rare but serious diabetic complications related to SGLT2 inhibitors, such as diabetic ketoacidosis (including sometimes with only mildly elevated glucose)
- Kidney-related monitoring
For metformin, key concerns include:
- Gastrointestinal side effects (such as nausea or diarrhea)
- Risk of lactic acidosis in people with significant kidney impairment or certain other high-risk situations, which is why kidney function is monitored
Who should not take empagliflozin/metformin, or who needs extra caution?
This combination generally requires careful evaluation in people with:
- Significant kidney disease (because metformin dosing/safety depends on kidney function, and empagliflozin effectiveness and safety also depend on kidney function)
- Conditions that increase risk for dehydration or ketoacidosis
- Situations where clinicians may temporarily stop the drug (for example, around surgery or severe acute illness), depending on individual risk
How is the combination typically started and adjusted?
Clinicians usually:
- Start at a dose based on kidney function, prior diabetes treatment, and tolerability.
- Adjust over time to reach glycemic goals while watching for side effects.
- Reassess kidney function periodically, since both components depend on renal status.
How does this combination compare with taking empagliflozin and metformin separately?
The main practical difference is that the fixed combination can simplify the regimen (fewer pills). Clinically, the expected effects depend on the same underlying drugs and doses. If a patient needs a metformin-only or empagliflozin-only dose adjustment, separate prescriptions can make fine-tuning easier.
What patents or exclusivity matter for this product?
If you’re researching commercial availability or patent status for empagliflozin/metformin hydrochloride tablets, DrugPatentWatch.com is a useful place to track patent and exclusivity information for specific products and combinations. You can search there for the relevant listing: https://www.drugpatentwatch.com/
Sources:
1 DrugPatentWatch.com